Gareth Jones recalls witnessing a scene in a Dublin pub when a man fired a shoe at a TV screen at the announcement of the second AIB bank bailout. “Th(...)

 Merrion Pharmaceuticals chief executive Dr John Fox

Merrion Pharmaceuticals says its survival is dependent on Declan Ryan’s Irelandia Investments not calling in an overdue loan as it reported a doubling(...)

Drugmaker Novo Nordisk demoted company president Kaare Schultz 15 months after putting him in line to become the next chief executive, prompting him t(...)

Bank of Ireland gained 1.35 per cent to close the day at 37.5 cents. Its chief executive, Richie Boucher, said the bank would in future look to grow in the UK through bolt-on acquisitions, though he indicated there were no immediate plans. Photograph: Aidan Crawley

European stocks rose yesterday, trimming their worst weekly loss of the year, as the Stoxx Europe 600 Index added 0.3 per cent. The market in Dubli(...)

Traders work at their screens in front of the German share price index DAX board at the stock exchange in Frankfurt yesterday. Photograph: Pawel Kopczynski/Reuters

Markets rose amid hopes that the European Central Bank’s (ECB) €1.14 trillion stimulus plans will spark economic growth in the region.Analysts said t(...)

The upward Iseq movement was helped by a 2.55% climb for one of its biggest stocks, Ryanair. Photograph: Alan Betson / The Irish Times

Concern about the outcome of a Greek election is likely to translate into weeks of nervous equity markets across the euro zone, analysts forecast.Eur(...)

 Dr John Fox, chief executive, Merrion Pharmaceuticals. Photograph: Eric Luke / The Irish Times

Merrion Pharmaceuticals has blamed foreign exchange weakness for a 4 per cent fall in revenues in the first half of the year.The Irish group’s revenue(...)

Merrion Pharmaceuticals chief executive John Fox. Photograph: Eric Luke

Merrion Pharma is back on the active list. The Elan spin-off which effectively went into hibernation during the recession has re-emerged this year un(...)

Dalata, the hotel company run by former Jurys chief executive Pat McCann (above), rose 1.61 per cent to €3.15. It was among six potential bidders named by ‘The Irish Times’ yesterday as being in the running for the €400 million Moran’s hotel group. Photograph: Brenda Fitzsimons

The Iseq nudged ahead by a modest 0.2 per cent yesterday, as European stocks held their ground after swinging between gains and losses throughout the(...)

Investors have been buying Ryanair since Monday, when it announced a third-quarter loss that was in line with predictions, and signalled that a strategic shift commenced in September is beginning to find favour with travellers.  Photograph: Eric Luke

Some optimism returned to European markets as stocks advanced for the first time in four days.Despite a period of misery, stretching back to January 2(...)